Part two of the myopia online course focuses on evaluating the effectiveness of myopia control interventions and the management of more complex clinical cases.
The Medicine & Healthcare products Regulatory Agency (MHRA) has approved the first licensed low-dose atropine (LDA) treatment for slowing the progression of childhood myopia.